Details of the Drug Combinations

General Information of This Drug (ID: DMS2M7O)

Drug Name

Deferiprone DMS2M7O

Synonyms

Ferriprox (TN)

Indication

Disease Entry	ICD 11	Status	REF
Beta thalassemia	3A50.2	Approved	[1]
Iron overload disease	5C64.10	Approved	[1]
Thalassemia	3A50	Approved	[2]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

3 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Deferoxamine + Deferiprone	DC7PNEB	Deferoxamine	Cardiovascular Diseases	[3]
Deferoxamine + Deferiprone	DCUXU5C	Deferoxamine	Hemochromatosis	[4]
Deferiprone + Acetylcysteine	DCDGS04	Acetylcysteine	Diabetes Mellitus	[5]
------------------------------------------------------------------------------------

References

1	Deferiprone FDA Label
2	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7456).
3	ClinicalTrials.gov (NCT00115349) Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases
4	ClinicalTrials.gov (NCT00349453) Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients
5	ClinicalTrials.gov (NCT02882477) Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy